The European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines recommend both ALT and USG for NAFLD screening in children21. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.